This lack of correlation can be crucial to consider when utilizing AFP as a diagnostic tool for HCC because it indicates that AFP levels in the blood cannot adequately represent the degree of liver damage or inflammation in a patient with HCC caused by HCV (evidenced by a 60% sensitivity rate). This evidence concerns the gene AFP and hepatocellular carcinoma.